This open enrollment, choose a plan that includes access to our world-class providers. Get better care now

Menu
Search

Roger Tsien Receives Neurosciences Prize

 

September 21, 2005  |  

The University of North Carolina (UNC) at Chapel Hill has named Roger Tsien, Ph.D., University of California, San Diego (UCSD) professor of pharmacology, chemistry and biochemistry, the recipient of the fifth annual Perl-UNC Neuroscience Prize.

The prize carries a $10,000 award and is given to recognize a seminal achievement in neuroscience. Tsien was recognized for developing molecular indicators that have revolutionized the optical monitoring of neurons. He has developed a wide variety of tools for optically monitoring the structure and function of cells and molecules in the nervous system, including calcium indicator dyes, genetically coded protein biosensors and modifications to green fluorescent protein, GFP. These tools have made it possible for scientists to visualize signaling processes in nerve cells both in cell culture and in the brains of living animals.

Tsien, a Howard Hughes Medical Institute investigator, is a member of the Institute of Medicine, which advises the nation on improving health, and the National Academy of Sciences. His laboratory's goal is to gain a better understanding of signaling inside individual living cells, in neuronal networks and in tumors,. His team designs, synthesizes and uses new molecules that detect or manipulate biochemical signals.

Previous recipients of the prize are Dr. David Julius of the University of California at San Francisco; Dr. Roderick MacKinnon of Rockefeller University; co-recipients Dr. Linda Buck of the Fred Hutchinson Cancer Research Center in Seattle and Dr. Richard Axel of Columbia University; and, last years recipient, Dr. Yves Barde of the Biocenter at the University of Basel in Switzerland.

News Media Contact:

Sue Pondrom, 619-543-6163, spondrom@ucsd.edu




Media Contact

Share This Article


Related News

11/12/2019
National attention has been drawn to the plight of patients who have experienced the unintended side effects of prolonged ICU care such as memory loss and muscle weakness. Now, a research team led by ...
11/7/2019
UC San Diego Health hospitals in Hillcrest and La Jolla have received grades of ‘A’ for excellence in safety and quality for the Fall 2019 Leapfrog Hospital Safety Grade report.
11/5/2019
Of the 3.5 million breast cancer survivors in the US, one in 5 will be diagnosed with a painful swelling condition called lymphedema, which can occur as a consequence of lymph nodes being removed. UC ...
10/28/2019
UC San Diego Health opens a new clinic in Eastlake that offers express care and imaging capabilities with primary care opening late 2019.



Follow Us